OTC · NXEN
Nexien BioPharma, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Oct 7, 2026, 12:18 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.08K
- P/E ratio
- -0.04
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.01
- Volume
- 20.16K
- Avg. volume
- 9.83K
Price performance · NXEN
NXEN price history
1M range · 1 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
NXEN closed at $0.00 after 1 trading sessions, up 0.00% for the selected period.
No results
At least two price observations are needed to draw this chart.
Latest NXEN news
The latest Smart Investors Daily articles mentioning NXEN.
Stock researchCompany · Overview
Company
Market Activity
Research & News
NXEN research
Overview
Company profile and research snapshot.
Company profile
NEXIEN BIOPHARMA INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
